Edition:
English
العربية
Français
فارسی
العربية
Français
فارسی
Facebook
Twitter
subscribe
search
Home
Israel & the Region
Jewish Times
Israel Inside
The Blogs
Startup Israel
Newsletters
The Daily Edition
What Matters Most Today
Startup Daily
Updates from Silicon Wadi
The Weekend Edition
The Best Reads of the Week
Partners
The Times of Israel
Atlanta
Atlanta Jewish Times
New Jersey
The Jewish Standard
New York
The Jewish Week
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
For Publishers
Become a Times of Israel Partner
search
pharmaceuticals
April 11, 2018, 12:19 am
Mylan buys rights to Israel-developed Multiple Sclerosis treatment
MS drug developed by Mapi Pharma requires a once-monthly injection instead of 3 times a week
By
TOI staff
February 8, 2018, 9:17 pm
Teva chief reports ‘strong progress’ in restructuring plan
CEO Kåre Schultz says company headquarters will remain in Israel despite shake-up that will slash a quarter of local workforce
By
Josef Federman
January 14, 2018, 4:28 pm
US okays 1st drug to fight ‘Jewish’ breast cancer gene
Lynparza approved by FDA for patients with the inherited BRCA mutations who have undergone chemotherapy
By
AP
and
TOI staff
July 24, 2017, 3:25 pm
Israeli drug maker NeuroDerm sold to Japanese pharma giant for $1.1b
Sale to Mitsubishi Tanabe is largest-ever of Israeli healthcare company; firm developing delivery methods for meds that fight Parkinson's symptoms
By
TOI staff
June 11, 2017, 5:53 pm
Teva shares rise in Tel Aviv as migraine results buoy investors
Drug is expected to lessen headache for pharma firm, which is facing stiff competition for its flagship anti-MS treatment Copaxone
By
Shoshanna Solomon
April 13, 2017, 12:29 pm
Kibbutz duo-turned-entrepreneurs on quest to whip gut bugs
Israeli biotech firm RedHill is conducting late-stage clinical trials to tackle Crohn's disease and the ulcer-generating H. pylori bacteria
By
Shoshanna Solomon
August 3, 2016, 8:21 am
Teva completes $40b purchase of Allergan generics arm
CEO of Israeli drugs giant says deal, which puts it among top 10 global pharmaceutical firms, won't push up medicine prices
By
Joe Dyke
May 4, 2016, 12:12 pm
Frutarom makes fifth acquisition of 2016
With 17 new acquisitions in the past 17 months, the world's seventh-biggest flavorings firm is aiming for $2 billion in annual sales by 2020
By
TOI staff
August 10, 2015, 4:54 pm
Israeli biotech firms to seek deals in Italy
Dozens of life science companies from Israel will attend a special event in Milan next month
By
David Shamah
July 27, 2015, 1:17 pm
Israel’s Teva buys part of Allergan drug company for $40.5 billion
In largest deal in country's history, pharmaceutical giant acquires Dublin-based firm's generic drug business, mostly for cash
By
AFP
,
AP
and
TOI staff
July 23, 2015, 5:32 pm
Mylan foundation to block Teva pharma’s hostile takeover bid
Independent group warns Israeli giant's purchase of the US drug company will reduce competition, increase prices
By
AFP
June 30, 2015, 4:58 pm
Merck CEO sees firm’s future intertwined with Israel’s
15% of pharma firm Merck KgaA's products have Israeli roots, and now an Israeli start-up will help the firm grow in new directions
By
David Shamah
June 24, 2015, 5:07 pm
With microchip implant, doctors can administer meds remotely
Israeli pharmaceutical giant Teva is teaming up with a US tech firm in the first-ever deal to use biochips to deliver pharmaceutical dosages
By
David Shamah
April 27, 2015, 7:47 pm
Mylan rebuffs Teva again; calls bid low, insincere
Generic drug company rejects $40.1-billion takeover offer from Israeli pharmaceutical power for second time
By
AFP
April 21, 2015, 6:11 pm
Teva offers to buy Mylan in $40 billion deal
Transaction would produce a pharmaceutical behemoth, possibly drawing the attention of regulators
By
TOI staff
and
AP
Load More